0,909  0,005  Antiinflammatory
0,716  0,005  Hepatic disorders treatment
0,681  0,006  Antipsoriatic
0,647  0,009  Cardiovascular analeptic
0,645  0,008  Immunosuppressant
0,647  0,014  Respiratory analeptic
0,643  0,011  Antiallergic
0,667  0,036  Apoptosis agonist
0,625  0,006  UGT1A4 substrate
0,608  0,009  Nitric oxide antagonist
0,582  0,007  Vascular (periferal) disease treatment
0,580  0,015  Analeptic
0,568  0,017  Bone diseases treatment
0,552  0,015  Cardioprotectant
0,545  0,010  Tumour necrosis factor alpha release inhibitor
0,566  0,034  Cyclophilin D inhibitor
0,566  0,034  Antidiabetic
0,545  0,017  Inflammatory Bowel disease treatment
0,529  0,005  Antiacne
0,528  0,014  Metabolic disease treatment
0,502  0,006  Prostatic (benign) hyperplasia treatment
0,505  0,019  Antiosteoporotic
0,474  0,007  Contraceptive
0,480  0,013  Antineoplastic enhancer
0,502  0,037  Antiobesity
0,464  0,007  Prostate disorders treatment
0,478  0,027  Immunomodulator
0,484  0,042  Antileukemic
0,439  0,005  Interleukin 6 antagonist
0,491  0,058  Antineoplastic (solid tumors)
0,425  0,005  Antitussive
0,423  0,007  Pneumotoxic
0,449  0,041  Cholesterol antagonist
0,410  0,010  UGT2B7 substrate
0,431  0,037  Antifungal
0,441  0,047  Antiasthmatic
0,400  0,011  Hair growth stimulant
0,435  0,051  Atherosclerosis treatment
0,431  0,057  Transcription factor NF kappa B inhibitor
0,390  0,016  Antiparkinsonian, rigidity relieving
0,369  0,005  UGT2B9 substrate
0,381  0,023  Sodium/bile acid cotransporter inhibitor
0,417  0,063  Rheumatoid arthritis treatment
0,372  0,020  UGT1A1 substrate
0,374  0,023  UDP-glucuronosyltransferase substrate
0,410  0,062  Antipruritic, allergic
0,368  0,022  Abortion inducer
0,392  0,046  Antihypercholesterolemic
0,381  0,036  NOS2 expression inhibitor
0,401  0,059  Toll-Like receptor 7 agonist
0,381  0,041  CTGF expression inhibitor
0,384  0,045  AR expression inhibitor
0,336  0,005  Contraceptive male
0,393  0,063  Toll-Like receptor agonist
0,341  0,012  Antiviral (Influenza A)
0,371  0,046  Lipoprotein disorders treatment
0,343  0,018  Antiseptic
0,364  0,040  UGT2B4 substrate
0,362  0,041  Cytotoxic
0,398  0,080  Antineoplastic (breast cancer)
0,317  0,005  Choleretic
0,354  0,052  NOS3 expression inhibitor
0,344  0,044  Sensitization
0,333  0,043  Proliferative diseases treatment
0,309  0,019  Lipocortins synthesis antagonist
0,376  0,088  Antibacterial
0,375  0,088  TNF expression inhibitor
0,310  0,028  Antiviral (Influenza)
0,347  0,066  Prostate cancer treatment
0,296  0,019  Tumour necrosis factor antagonist
0,284  0,009  Expectorant
0,299  0,030  Hepatoprotectant
0,285  0,022  Interferon gamma antagonist
0,316  0,060  CYP2C19 substrate
0,278  0,026  Antipruritic, non-allergic
0,257  0,006  Hedgehog signaling inhibitor
0,281  0,033  P-glycoprotein inhibitor
0,333  0,085  CYP3A4 substrate
0,273  0,028  Antieczematic atopic
0,275  0,030  Systemic lupus erythematosus treatment
0,302  0,060  Antihypoxic
0,284  0,045  Chemopreventive
0,318  0,079  ICAM1 expression inhibitor
0,280  0,043  Sigma receptor agonist
0,305  0,068  Spasmolytic
0,275  0,038  RNA-directed DNA polymerase inhibitor
0,240  0,004  5-Alpha-reductase inhibitor
0,241  0,007  Mucolytic
0,360  0,130  Autoimmune disorders treatment
0,364  0,134  Caspase 9 stimulant
0,323  0,093  CYP2C9 substrate
0,309  0,082  Antithrombotic
0,255  0,027  Skin irritative effect
0,340  0,114  Analgesic
0,253  0,028  Anesthetic
0,248  0,025  Antipruritic
0,255  0,032  Sepsis treatment
0,265  0,044  Anesthetic general
0,239  0,020  Antifungal enhancer
0,230  0,011  Constipation treatment
0,237  0,020  Cholesterol synthesis inhibitor
0,268  0,052  Psychostimulant
0,245  0,032  UGT1A3 substrate
0,340  0,134  Alzheimer's disease treatment
0,225  0,022  UGT2B10 substrate
0,214  0,012  Androgen antagonist
0,267  0,066  5 Hydroxytryptamine uptake stimulant
0,266  0,067  Hypoglycemic
0,210  0,014  UGT2B1 substrate
0,214  0,018  Endometrios treatment
0,227  0,031  CNS active muscle relaxant
0,288  0,094  Apoptosis antagonist
0,196  0,003  Andropause treatment
0,204  0,013  Contraceptive female
0,210  0,019  Farnesoid X receptor antagonist
0,255  0,065  Cytostatic
0,213  0,022  Arachidonic acid antagonist
0,238  0,048  Non-steroidal antiinflammatory agent
0,195  0,010  Actinic keratosis treatment
0,260  0,076  Chemoprotective
0,225  0,046  Macular degeneration treatment
0,184  0,005  Androgen agonist
0,203  0,026  Antihyperlipoproteinemic
0,181  0,007  Anabolic
0,227  0,054  Antihelmintic
0,231  0,059  Antialcoholic
0,235  0,063  Antihypertriglyceridemic
0,226  0,055  Neurotrophic factor enhancer
0,185  0,016  Pregnane X receptor agonist
0,174  0,008  Paget's disease treatment
0,247  0,083  Gastrin inhibitor
0,168  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,250  0,093  Antineoplastic (pancreatic cancer)
0,175  0,019  GABA C receptor antagonist
0,159  0,005  Narcotic antagonist
0,165  0,011  Aromatase inhibitor
0,201  0,048  Liver fibrosis treatment
0,167  0,014  Opioid kappa receptor antagonist
0,161  0,011  UGT2B11 substrate
0,225  0,077  Antineoplastic (lymphoma)
0,238  0,090  UGT1A9 substrate
0,151  0,005  Liver X receptor agonist
0,193  0,048  Toxic, respiratory center
0,174  0,031  Adenylate cyclase stimulant
0,148  0,006  Anticholelithogenic
0,217  0,076  Antiparasitic
0,191  0,050  Antirickettsial
0,148  0,008  Glycine receptor antagonist
0,220  0,082  Hypolipemic
0,267  0,130  GST A substrate
0,151  0,015  SULT1E1 substrate
0,181  0,046  Antidiarrheal
0,216  0,081  UGT1A6 substrate
0,163  0,031  Microtubule formation inhibitor
0,237  0,106  Antiepileptic
0,176  0,046  Antidiabetic (type 1)
0,156  0,027  HDL-cholesterol increasing
0,133  0,004  5-Alpha-reductase 1 inhibitor
0,240  0,113  GST M1-1 substrate
0,136  0,009  Na+ K+ transporting ATPase inhibitor
0,252  0,126  FMO1 substrate
0,259  0,137  Calcium channel activator
0,140  0,020  ABCA1 expression enhancer
0,215  0,097  Antipyretic
0,193  0,076  Sedative
0,148  0,031  Antineoplastic antibiotic
0,216  0,100  DNA synthesis inhibitor
0,243  0,127  Multiple sclerosis treatment
0,149  0,034  Alcohol dehydrogenase substrate
0,209  0,094  Antihypotensive
0,118  0,004  Hypogonadism treatment
0,152  0,038  Ca2+-transporting ATPase inhibitor
0,221  0,108  Antineoplastic (ovarian cancer)
0,169  0,057  UGT2B15 substrate
0,116  0,005  5-Alpha-reductase 2 inhibitor
0,168  0,060  Hexokinase inhibitor
0,225  0,117  Antineoplastic (multiple myeloma)
0,121  0,014  Hyperparathyroidism treatment
0,156  0,051  Cachexia treatment
0,111  0,008  Progesterone antagonist
0,251  0,149  Antineoplastic (endocrine cancer)
0,179  0,077  Antiviral (Hepatitis)
0,154  0,055  MAP3K9 inhibitor
0,145  0,047  Protein-tyrosine phosphatase 1B inhibitor
0,153  0,055  Antifungal (Cryptococcus)
0,141  0,044  Menstruation disorders treatment
0,164  0,066  Protein-tyrosine phosphatase inhibitor
0,143  0,047  Autism spectrum disorders treatment
0,219  0,124  Anxiolytic
0,134  0,041  GABA C receptor agonist
0,136  0,044  SULT1A1 substrate
0,190  0,099  Angiogenesis stimulant
0,095  0,004  Farnesoid X receptor agonist
0,101  0,011  Hypercalcemia treatment
0,206  0,116  Antineoplastic (sarcoma)
0,107  0,017  Glycine receptor agonist
0,113  0,024  Keratolytic
0,134  0,045  GABA receptor agonist
0,124  0,035  Opioid antagonist
0,105  0,016  Estrogen agonist
0,189  0,102  VCAM1 expression inhibitor
0,095  0,007  Postcoital contraceptive
0,096  0,011  SULT2A1 substrate
0,127  0,042  Estrogen antagonist
0,199  0,114  Antioxidant
0,172  0,087  Sleep disorders treatment
0,096  0,012  Estrogen receptor beta agonist
0,107  0,024  CDC25A inhibitor
0,209  0,126  Antidiabetic (type 2)
0,090  0,007  Anesthetic inhalation
0,138  0,056  DNA polymerase I inhibitor
0,085  0,005  Pregnane X receptor antagonist
0,179  0,100  Anticonvulsant
0,154  0,076  Melanin inhibitor
0,139  0,062  Cocaine dependence treatment
0,149  0,072  Acaricide
0,081  0,005  Parathyroid hormone antagonist
0,106  0,032  GABA A receptor agonist
0,145  0,072  Protein kinase stimulant
0,078  0,006  Liver X receptor antagonist
0,107  0,035  Bile acid receptor antagonist
0,232  0,160  Ulceration
0,147  0,078  Raynaud's phenomenon treatment
0,142  0,074  SULT1A3 substrate
0,134  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,076  0,009  Retinoid X receptor agonist
0,114  0,048  GST T1-1 substrate
0,072  0,006  GABA uptake inhibitor
0,152  0,088  Muscular dystrophy treatment
0,110  0,046  Estrogen receptor beta antagonist
0,076  0,013  Acetyl-CoA transferase 2 inhibitor
0,152  0,089  Muscle relaxant
0,096  0,033  Analgesic, opioid
0,126  0,064  Antiviral (Hepatitis B)
0,098  0,035  Antibiotic
0,137  0,076  Antiparkinsonian, tremor relieving
0,080  0,022  Postmenopausal disorders treatment
0,196  0,139  Transcription factor STAT3 inhibitor
0,145  0,089  Mutagenic
0,065  0,010  Retinoid X alpha receptor agonist
0,173  0,121  Aldehyde oxidase inhibitor
0,095  0,044  Transcription factor NF kappa B stimulant
0,071  0,021  Lipocortins synthesis agonist
0,108  0,058  Nav1.1 sodium channel blocker
0,084  0,035  Leukotriene synthesis inhibitor
0,194  0,146  Tyrosine 3 hydroxylase inhibitor
0,057  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,052  0,005  Liver X receptor alpha antagonist
0,084  0,038  Opioid mu receptor antagonist
0,114  0,070  Shock treatment
0,059  0,015  Estrogen receptor alpha agonist
0,056  0,013  Glucocorticoid antagonist
0,085  0,041  Estrogen receptor alpha antagonist
0,062  0,018  Aldosterone antagonist
0,131  0,088  Skeletal muscle relaxant
0,046  0,004  Hedgehog signaling activator
0,094  0,053  Antidote, mercury
0,158  0,118  CYP2B6 inhibitor
0,064  0,026  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,047  0,009  Tubulin agonist
0,067  0,030  Heme oxygenase stimulant
0,048  0,013  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,061  0,025  Aconitate hydratase inhibitor
0,049  0,014  RNA-directed RNA polymerase stimulant
0,043  0,010  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,120  0,087  Vanilloid 1 agonist
0,108  0,075  TRPA1 agonist
0,043  0,011  Liver X receptor beta antagonist
0,070  0,039  Glutamate (mGluR6) antagonist
0,048  0,017  Kainate receptor agonist
0,050  0,020  Liver X receptor alpha agonist
0,052  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,084  0,056  Antispirochetal
0,034  0,006  Vitamin D receptor antagonist
0,065  0,039  Cannabinoid CB1 receptor agonist
0,035  0,008  Nicotinic acid receptor 2 antagonist
0,164  0,137  Antineoplastic (non-small cell lung cancer)
0,032  0,007  GRP78 expression inhibitor
0,028  0,004  Telomerase stimulant
0,030  0,007  Progesterone agonist
0,029  0,007  Retinoic acid gamma receptor agonist
0,126  0,105  Eye irritation, high
0,084  0,063  Ornithine decarboxylase inhibitor
0,024  0,005  Vitamin D receptor agonist
0,088  0,069  Prolactin inhibitor
0,092  0,073  Sulfotransferase substrate
0,040  0,021  Glucose-6-phosphate dehydrogenase inhibitor
0,029  0,011  Vanilloid 2 agonist
0,025  0,007  Retinoid X beta receptor antagonist
0,040  0,023  Retinoid X receptor antagonist
0,080  0,063  Inducible nitric-oxide synthase inhibitor
0,037  0,020  Retinoid X alpha receptor antagonist
0,105  0,090  Growth stimulant
0,098  0,083  Antifungal (Aspergillus)
0,178  0,163  Renal disease treatment
0,060  0,046  Antimycoplasmal
0,024  0,010  Retinoic acid alpha receptor antagonist
0,026  0,013  Retinoic acid receptor agonist
0,028  0,015  Retinoid X gamma receptor antagonist
0,043  0,030  Opioid kappa receptor agonist
0,022  0,010  Retinoic acid beta receptor agonist
0,046  0,033  Microtubule stabilization
0,025  0,013  CYP24 inhibitor
0,039  0,028  Membrane dipeptidase inhibitor
0,032  0,021  Cholesterol ester transfer protein antagonist
0,164  0,154  Interleukin agonist
0,084  0,075  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,046  0,037  Mineralocorticoid receptor antagonist
0,105  0,096  Acetylcholinesterase inhibitor
0,071  0,062  Vanilloid 4 agonist
0,136  0,128  ATPase inhibitor
0,127  0,120  Uterine stimulant
0,079  0,072  T cell inhibitor
0,089  0,083  Ferrochelatase inhibitor
0,019  0,013  Progesterone receptor B antagonist
0,114  0,108  Psychosexual dysfunction treatment
0,055  0,050  Opioid delta receptor antagonist
0,018  0,013  Retinoic acid receptor antagonist
0,013  0,008  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,013  0,009  Glucocorticoid agonist
0,029  0,026  ATP citrate lysase inhibitor
0,062  0,059  Ankylosing spondylitis treatment
0,012  0,009  Retinoic acid beta receptor antagonist
0,021  0,019  Prostaglandin F2 alpha agonist
0,011  0,009  Retinoic acid receptor gamma antagonist
0,134  0,133  Teratogen
0,021  0,019  Retinoid X gamma receptor agonist
0,017  0,016  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,196  0,196  Interleukin 2 agonist

